Testing effectiveness (Phase 2)Study completedNCT01147640
What this trial is testing
Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections
Who this might be right for
Complicated Intra-abdominal Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 122